Here are the 10-K annual reports from Keen Vision Acquisition Corporation Units (KVACU) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow KVACU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KVACU filings page.
Keen Vision Acquisition Corporation, a British Virgin Islands-based SPAC, filed its annual report detailing its structure, deal activity and finances. The company raised $149,500,000 in its IPO and, with a private placement, initially placed $151,368,750 in a U.S. trust account for public shareholders.
Heavy redemptions withdrew $92,398,989, $18,091,743 and $44,294,336.90, leaving trust investments of $57,003,115 and cash outside the trust of $11,206 as of December 31, 2025. Net income for 2025 was $1,910,263, driven mainly by interest and dividends on trust investments.
The SPAC’s original merger agreement with Medera Inc. was terminated and replaced on February 26, 2026 by a binding letter of intent with Novoheart Group Limited, valuing NVH at $100,000,000 and requiring at least $10,000,000 available cash at closing. Keen Vision has extended its business combination deadline multiple times and, as of the report, has until April 27, 2026 to complete a deal before it must liquidate and return remaining trust funds to public shareholders.